开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2019-02-14 chuttle

说版面费巨高，是真的吗？

294 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2022-05-31 124060e8m50(暂无昵称)

审稿速度:12.0 | 投稿命中率:25.0
经验分享：不是很容易
审稿好贵

113 0

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2022-05-25 ms1000000867109818

这个期刊就算没有接受，也必须先交****费吗？

141 0

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2021-12-29 衣谷

文章类型和选刊有关系吗？

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

选刊时有什么原则吗？

0 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2020-06-16 146f6ef6m90(暂无昵称)

。。。官网上好像说是open choice啊

200 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2019-05-21 145d8d45m50暂无昵称

花费多少liwg660 2016-01-15 发表::
研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表:
刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。

感觉编辑部很客气和耐心。

liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。

253 0

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2019-05-02 ms7574356931796630

效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。

230 0

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2019-04-01 Ryo1992

审稿速度:2.0
经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。

234 0

[GetPortalCommentsPageByObjectIdResponse(id=566751, encodeId=b722566e5107, content=说版面费巨高，是真的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=294, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=597b2378660, createdName=chuttle, createdTime=Thu Feb 14 00:00:00 CST 2019, time=2019-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223725, encodeId=f7631223e2576, content=审稿速度:12.0 | 投稿命中率:25.0 经验分享：不是很容易 审稿好贵, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lJzPAyicpV6U8icsOO3RuiaozENZ2ABYic1dDr1DV6RcLM2vGAawGKpEQvcVha9VD2U00GfnyFJJObOSeTEa5qfPyA/132, createdBy=47352456178, createdName=124060e8m50(暂无昵称), createdTime=Tue May 31 22:49:49 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222229, encodeId=7ad512222298d, content=这个期刊就算没有接受，也必须先交****费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efce6162787, createdName=ms1000000867109818, createdTime=Wed May 25 08:23:45 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086246, encodeId=997f1086246f9, content=文章类型和选刊有关系吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086245, encodeId=9912108624519, content=选刊时有什么原则吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=602370, encodeId=335b6023e09f, content=。。。官网上好像说是open choice啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=200, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Tue Jun 16 20:03:05 CST 2020, time=2020-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571274, encodeId=3a625e1274d4, content=花费多少liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。liwg660 2016-01-15 17:56:00 发表: 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。 感觉编辑部很客气和耐心。, beContent=liwg660 2016-01-15 发表:: 研究方向：药物疗效;; 审稿时间：约2个月 SCI(2014)：2.272 刚投一篇稿子，内容是头对头对比两种药物的效果和安全性。3周回复，2个审稿人。修回后编辑部说一个审稿人对一条回复有点保留意见，再改，接受。总共一个半月。感觉编辑部很客气和耐心。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6f685092941, createdName=145d8d45m50暂无昵称, createdTime=Tue May 21 00:00:00 CST 2019, time=2019-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=851146, encodeId=1bca8511460d, content=效率很高，1个半月接收。版面费非常贵，每页就要660刀，如果选择开源还要另外收钱，大部分文章都是由企业赞助的。中国人在上面发的很少，所以倒也不用担心国人灌水的问题。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=14215414107, createdName=ms7574356931796630, createdTime=Thu May 02 17:20:14 CST 2019, time=2019-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568976, encodeId=a8475689e6e0, content=审稿速度:2.0 经验分享：临床研究的稿子，一开始投clinical drug investigation，主编推荐投这个，而且可以帮我们转。最后因为版面费太贵了没同意。现在又投这个杂志，under review，不知道行不行了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200610/c539b8d8579243baa9c18cf460bedd7e/v2-7f6ee3b1a4f6e172f77fd2f3ebb54caf_hd.jpg, createdBy=29bd2245710, createdName=Ryo1992, createdTime=Mon Apr 01 17:28:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539496, encodeId=a37253949687, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=401, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=)]

2017-07-18 chengqi2017

一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的

401 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务